Tag: Institutional investors

While there is no single majority owner, major institutional investors collectively hold significant controlling stakes in most publicly traded pharmaceutical companies. The question, 'Who owns most of Big Pharma?', doesn't have a simple answer, as the ownership is distributed among thousands of shareholders, with a handful of large investment firms exercising considerable influence.

In 2022, over $25 billion in biopharmaceutical exports were from majority foreign-owned firms operating in the United States, highlighting the significant role international investment plays in the industry. This multifaceted financial landscape reveals that answering the question of who owns US pharma is far from straightforward, involving a mix of institutional, public, foreign, and venture capital ownership.